Tempest Therapeutics
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $486 | $0 | $0 | $0 |
Gross Profit | 243 | -155 | -88 | |
EBITDA | -16,582 | -10,129 | -9,043 | -7,448 |
EBIT | -16,242 | -10,226 | -9,198 | -7,536 |
Net Income | -13,813 | -10,556 | -9,570 | -7,904 |
Net Change In Cash | 486 | 0 | 0 | 0 |
Free Cash Flow | 22,875 | -10,197 | -5,759 | -7,354 |
Cash | 30,268 | 22,116 | 31,124 | 32,326 |
Basic Shares | 27,901 | 25,806 | 22,546 | 22,234 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -381 | -1,814 | -1,270 | |
EBITDA | -28,776 | -32,277 | -25,716 | |
EBIT | -29,157 | -34,091 | -26,986 | |
Net Income | -41,843 | -29,491 | -36,778 | -29,550 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -435 | -27,527 | -31,634 | -26,092 |
Cash | 30,268 | 39,230 | 31,230 | 51,829 |
Basic Shares | 27,901 | 15,416 | 11,548 | 3,790 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.31 |
2024-09-30 | -$0.41 |
2024-06-30 | -$0.42 |
2024-03-31 | -$0.36 |
